x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

54:31

In the trenches of pharma manufacturing

Molecule to Market: Inside the outsourcing space ·

2022/04/22

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ray Kaczmarek, Chief Executive Officer at Genezen. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ray, covering: Translating military life lessons into key business leadership - taking care of your people, having operational discipline and allowing people to be leaders. Invaluable learnings from taking a drug from clinical trials to

en

38:38

From Sweden with Science

Molecule to Market: Inside the outsourcing space ·

2022/04/11

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Hans J Johansson, Global Applications Director at Purolite. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Hans, covering: A career spent developing ideas and creating products that produce new applications for customers and commercial success. Driving the Purolite business unit from the ground-up from a lab bench to a commercial scale

en

48:27

The niche, niche CDMO with enviable patient reach

Molecule to Market: Inside the outsourcing space ·

2022/04/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jim Hall, President at Lifecore Biomedical Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jim, covering: What a period working on the sponsor/buyer side taught him about getting best out of your CROs and CDMOs The challenges of doubling in size twice in just 10 years and not getting ‘too far out over your skis’ Building a culture

en

28:26

Diaries of DCAT

Molecule to Market: Inside the outsourcing space ·

2022/04/06

Last week marked the return of DCAT in New York City. A prestigious event that’s open to companies engaged in the Biotech and Pharmaceutical manufacturing space… With the massive return this year of events. Your host, Raman Sehgal, decided to shake things up this year and do things differently, taking your favourite life science podcast Molecule to market with him… Equipped with only a laptop and a microphone, he hit the event space in style and interviewed some great guests along the way. Listen to

en

40:14

Finland’s Viral Vector Manufacturer of Happinesses

Molecule to Market: Inside the outsourcing space ·

2022/03/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Magnus Gustafsson, formerly at the time of recording Head of Global Business Development now Chief Business Officer at Biovian. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Magnus, covering: The advantages and disadvantages of viral vector products, including the challenge of needing to balance cost with patient access. Insights

en

50:52

From corporate rebel to CDMO entrepreneur

Molecule to Market: Inside the outsourcing space ·

2022/02/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Hanns-Christian Mahler CEO at ten23 health. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Hanns, covering: Transitioning from the structure and scale of Merck, Roche and Lonza into an entrepreneurial start-up CDMO leader. Having a business purpose focused on the triple-bottom line that is not just profit - patients, people and

en

48:31

Mr digital transformation

Molecule to Market: Inside the outsourcing space ·

2022/02/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Leitham, Senior Vice President and General Manager at Aspen Technology. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with David, covering: Why a transformative approach is now needed to better deal with new therapeutics and modalities. The pandemic as the inflexion point for companies in pharma to truly adapt technology and create

en

57:34

The Latin American logistics leader

Molecule to Market: Inside the outsourcing space ·

2022/02/09

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jaqueline Escotero, Regional Vice President for Latin America at World Courier. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jaqueline, covering: The misconnections, characteristics and challenges of doing business in Latin America’s pharmaceutical sector. The immense complexity and level of responsibility involved in vaccine storage

en

46:17

The opportunistic entrepreneur

Molecule to Market: Inside the outsourcing space ·

2022/01/31

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ross Burn, Chief Executive at CatSci. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ross, covering: Creating a successful business from an opportunistic AZ spin-out. Never being afraid to pivot in-line with the needs of the market and have big aims like becoming an innovative medicines development partner with a $1 billion

en

05:46

The Floundering Founder, a lifetime of knowledge for...

Molecule to Market: Inside the outsourcing space ·

2022/01/25

In this special bonus episode of Molecule to Market, our host discusses his very first book launch ‘The Floundering Founder’ which is now available on Amazon and Kindle. Whilst you know him as the host of Molecule to Market, Raman has built up an impressive career in marketing, leadership and sector disciplines over the past 20+ years working within the global pharmaceutical and biotech outsourcing sector. Over the past twelve months of that career, Raman has spent an hour each day working on his

en

54:07

From Pharmacy to $1B family-owned CDMO

Molecule to Market: Inside the outsourcing space ·

2022/01/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Soelkner, Managing Director at Vetter. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: The fascinating and humble origin story of one of the world’s most well respected sterile filling specialists. Peter’s journey of leading Vetter in becoming a $1bn, 5500 person family-owned CDMO...alongside a fellow Managing

en

57:58

Roundtable: M&A trends in CDMO

Molecule to Market: Inside the outsourcing space ·

2022/01/18

In this special roundtable episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Jean-Jacques Mondoloni, Managing Partner WOMBAT CAPITAL Mark Quick, Executive Vice President Corporate Development at Recipharm Gerry Cox, Vice President at Pace Life Sciences Your host, Raman Sehgal, discusses M&A trends in the pharmaceutical and biotechnology supply chain, covering: What a real-life M&A deal in outsourcing looks like from the buyer, seller

en

28:22

The UK’s hidden life science gem

Molecule to Market: Inside the outsourcing space ·

2022/01/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michelle Duggan, Inward Investment Manager, Invest North East England. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Michelle, covering: Why is North East England becoming a UK hot spot for Health and Life Sciences. Collaborating and breaking down barriers to help create a super cluster of life sciences. The academic and industrial

en

40:54

Meet the potent powder expert

Molecule to Market: Inside the outsourcing space ·

2021/12/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chris Eccles, Chief Executive Officer at ChargePoint Technology. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chris, covering: The journey from a management buy-out (MBO) to running a £20m,100-person, global business. Benefit of investing in technology within sterile environments to avoid cross contamination and prevent expensive

en

33:59

Physician. Scientist. Entrepreneur.

Molecule to Market: Inside the outsourcing space ·

2021/12/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Go van Dam, CEO & Founder at TRACER. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Go, covering: The value of micro-dosing and fluorescent imaging in small patient populations at the preclinical proof of concept phase, and the benefits to investors, biotech and big pharma. The journey of stepping out of the operating theatre and into the

en

38:36

Hollywood DVDs to biotech drugs

Molecule to Market: Inside the outsourcing space ·

2021/12/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Devendra Mishra, Executive Director and Founder at Bio Supply Management Alliance (BSMA). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Devendra, covering: Being at the birth of biotech becoming a business and creating a network of 10k+ supply chain professionals. How we have just been through the most creative and productive period in

en

43:45

The big pharma sourcing specialist

Molecule to Market: Inside the outsourcing space ·

2021/11/29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Daniel Hogan, External Manufacturing Team Lead for the Americas at Bayer Pharmaceuticals. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Daniel, covering: Managing a portfolio of 30-50 CMO partners across OSD, aerosols, topicals and liquids. And why due diligence and careful CMO selection is vital given its 10 x harder to exit a

en

46:54

The Cleanroom Veteran

Molecule to Market: Inside the outsourcing space ·

2021/11/18

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Grant Merrill President & CEO at AES Clean Technology. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Grant, covering: Becoming the leader of the business that he dreamt of representing. The need for cleanrooms to work in an invisible way as the most critical square footage at the core of the facility. Having to keep up with demand during

en

46:10

The 4Cs every CDMO vendor should know

Molecule to Market: Inside the outsourcing space ·

2021/11/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Carl Turner, Vice President Supply Chain at Mayne Pharma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Carl, covering: Managing 30+ CDMOs across several drug delivery systems and having the unique perspective of being on the buy CMO side, but having visibility of the CMO sell side. The 4 Cs that Carl looks for in sourcing, evaluating

en

51:40

What next for trade events?

Molecule to Market: Inside the outsourcing space ·

2021/10/15

In this special events-themed episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Samuel Thangiah, co-founder of Life Science Integrates Tara Dougal, Head Of Content & Insights for Pharma at Informa Markets Edward McNamara, Vice President of Innovation Banking - Life Sciences at Cambridge Trust and the Co-Founder of BioXchange Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology event scene with his three guests,

en

256 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter